Global antibody response to Staphylococcus aureus live-cell vaccination.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Bröker, Barbara M
MetadataShow full item record
AbstractThe pathogen Staphylococcus aureus causes a broad range of severe diseases and is feared for its ability to rapidly develop resistance to antibiotic substances. The increasing number of highly resistant S. aureus infections has accelerated the search for alternative treatment options to close the widening gap in anti-S. aureus therapy. This study analyses the humoral immune response to vaccination of Balb/c mice with sublethal doses of live S. aureus. The elicited antibody pattern in the sera of intravenously and intramuscularly vaccinated mice was determined using of a recently developed protein array. We observed a specific antibody response against a broad set of S. aureus antigens which was stronger following i.v. than i.m. vaccination. Intravenous but not intramuscular vaccination protected mice against an intramuscular challenge infection with a high bacterial dose. Vaccine protection was correlated with the strength of the anti-S. aureus antibody response. This study identified novel vaccine candidates by using protein microarrays as an effective tool and showed that successful vaccination against S. aureus relies on the optimal route of administration.
CitationGlobal antibody response to Staphylococcus aureus live-cell vaccination. 2016, 6:24754 Sci Rep
AffiliationHelmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.
The following license files are associated with this item:
- A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
- Authors: Moscoso M, García P, Cabral MP, Rumbo C, Bou G
- Issue date: 2018 Jan 1
- Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis.
- Authors: Pellegrino M, Giraudo J, Raspanti C, Nagel R, Odierno L, Primo V, Bogni C
- Issue date: 2008 Feb 5
- Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis.
- Authors: Stegmiller NP, Barcelos EC, Leal JM, Covre LP, Donatele DM, de Matos Guedes HL, Cunegundes MC, Rodrigues RR, Gomes DC
- Issue date: 2016 Jun 24
- A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.
- Authors: Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, Pancari G, Fan H, Isett K, Burgess B, Bryan J, Brownlow M, George H, Meinz M, Liddell ME, Kelly R, Schultz L, Montgomery D, Onishi J, Losada M, Martin M, Ebert T, Tan CY, Schofield TL, Nagy E, Meineke A, Joyce JG, Kurtz MB, Caulfield MJ, Jansen KU, McClements W, Anderson AS
- Issue date: 2006 Apr
- Generation of a Novel Staphylococcus aureus Ghost Vaccine and Examination of Its Immunogenicity against Virulent Challenge in Rats.
- Authors: Vinod N, Oh S, Park HJ, Koo JM, Choi CW, Kim SC
- Issue date: 2015 Jul